<DOC>
	<DOC>NCT02815176</DOC>
	<brief_summary>Thrombotic biomarkers and angiographic characteristics were compared among the de novo patients of central serous chorioretinopathy (CSC), polypoidal choroidal vasculopathy (PCV) and the control.</brief_summary>
	<brief_title>Angiographic Characteristics of CSC, PCV Patients and Thrombotic Bio-markers</brief_title>
	<detailed_description />
	<mesh_term>Vascular Diseases</mesh_term>
	<mesh_term>Central Serous Chorioretinopathy</mesh_term>
	<mesh_term>Plasminogen</mesh_term>
	<mesh_term>Plasminogen Activator Inhibitor 1</mesh_term>
	<mesh_term>Plasminogen Inactivators</mesh_term>
	<criteria>CSC neurosensory detachment in optical coherence tomography (OCT) focal leakage in fluorescein angiography (FAG) and/or late choroidal hyperpermeability in indocyanine green angiography (ICGA) PCV subretinal and/or subretinal pigment epithelial fluid in OCT branching vascular network and/or polyps in ICGA Control epiretinal membrane (ERM) without underlying systemic, ophthalmic disease other than ERM Previous history of using steroid (oral, topical) Previous history of CSC/PCV Previous history or evidence of intraocular inflammation including uveitis Coexisting retinal or choroidal diseases History of allergic reaction to fluorescein or indocyanine green dye Underlying systemic conditions that could affect the thrombotic profiles (e.g. diabetes, hypertension, metabolic syndrome, coronary artery disease, cerebrovascular diseases, stroke, chronic renal failure, current smoker, pregnancy, sleep disorder)</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Plasminogen activator inhibitor-1</keyword>
	<keyword>Wide angle fluorescein angiography</keyword>
	<keyword>Choroid</keyword>
</DOC>